Lọc theo danh mục
  • Năm xuất bản
    Xem thêm
  • Lĩnh vực
liên kết website
Lượt truy cập
 Lượt truy cập :  21,973,262
  • Công bố khoa học và công nghệ Việt Nam

76.29

Y học lâm sàng

Nghiên cứu rối loạn lipid máu ở bệnh nhân đột quỵ não tại trung tâm đột quỵ não Bệnh viện Trung ương Quân đội 108

The study of the Dyslipidemia in patients suffering from strokes in Stroke Centre of Central Military Hospital No.108

Tạp chí Y Dược lâm sàng 108

2011

5

8-12

1859-2872

Background and Purpose: There are many researches about the relationship between dyslipidemia and the risk of stroke in the world. The results of these researches confirmed that dyslipidemia is the risky factor of ischemic stroke and the benefit of treatment for lipid-lowering on ischemic stroke, but for hemorrhagic stroke has not been clear. In Vietnam, a few studies about each ingredient of dyslipidemia in stroke have been carried out. Methods: The author studied on 116 patients with hemorrhagic stroke and 136 patients with ischemic stroke in Stroke Centre of Central Military Hospital No.108. All patients had been measured in total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triqlvceride (TG); and the results between two groups of patients were compared. Results: - There was no difference ofTG between two groups of patients. - The TC, LDL-C in the group of patients with ischemic stroke (5.1 + or - 0.8mmol/l; 3.36 + or - 0.93mmol/l) were higher than that in the group of patients with hemorrhagic stroke (4.7 + or - 1.13mmol/l; 2.75 + or - 1.0mmolll) respectively p 0.05; - Percentage of the total dyslipidemia, the high level of TC, LDL-C and the low level of HDL-C in the group of patients with ischemic stroke (82 percent; 47.8 percent; 46.3 percent, 27.5 percent) were higher than that in the group of patients with hemorrhagic stroke (61 percent; 29.3 percent; 27.6 percent; 7.8 percent). Conclusions: It is needed to treat dyslipidemia for the secondary prevention of ischemic stroke.

TTKHCNQG, CVv337